Search for Clinical Trial Results
Intraocular Melanoma - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis Condition: Uveal Melanoma Date: 2016-09-09 Interventions:
|
Recruiting |
Study Name: A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. Condition: Uveal Melanoma Date: 2015-11-06 Interventions: Drug: LXS196 |
Terminated |
Study Name: Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients Condition: Uveal Melanoma Date: 2009-06-25 Interventions: Biological: autologous dendritic cells electroporated with mRNA Autologous mature monocyte-derived dendr |
Completed |
Study Name: Treatment With Intravitreal Avastin for Large Uveal Melanomas Condition: Uveal Melanoma Date: 2008-01-08 Interventions: Drug: AVASTIN a single injection of Avastin at the outpatient clinic. This will be done as follows: the |
Recruiting |
Study Name: Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy Condition: Uveal Melanoma Date: 2014-08-20 Interventions: Drug: Crizotinib An anti-cancer drug acting as an ALK (ana |
Recruiting |
Study Name: Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma Condition: Uveal Melanoma Date: 2009-12-15 Interventions: Drug: CP-675,206 Patients will receive CP-675,206 at 15 mg/kg administered intravenously on day 1 of eve |
Recruiting |
Study Name: Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma Condition: Uveal Melanoma Date: 2007-04-11 Interventions: Procedure: Intraoperative ultrasonography Intraoperative ultrasonography will be used to determine plaqu |
Recruiting |
Study Name: Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma Condition: Uveal Melanoma Date: 2009-03-30 Interventions: Radiation: Hypofractionated linear accelerator radiotherapy 10 fractions of stereotactic linear accelera |
Completed |
Study Name: RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma Condition: Uveal Melanoma Date: 2010-12-01 Interventions: Drug: RAD001 (Everolimus) and Pasireotide (SOM230) LAR Patients will be treated with SOM-230 (pasireotid |
Active, not recruiting |
Study Name: A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma Condition: Uveal Melanoma Date: 2011-06-14 Interventions:
|